Terumo Corp (TSE:4543)
円 2,189 -38.5 (-1.73%) Market Cap: 3.23 Tn Enterprise Value: 3.33 Tn PE Ratio: 23.76 PB Ratio: 2.04 GF Score: 88/100

Q1 2026 Terumo Corp Earnings Call Transcript

Aug 7, 2025 / 08:00 AM GMT
Release Date Price: 円2530 (-1.21%)

Key Points

Positve
  • Terumo Corp (TRUMF) achieved record high quarterly revenue of 260 billion for Q1, with a 6% growth excluding foreign exchange impacts.
  • Operating profit grew significantly faster than revenue, reaching a record 55.9 billion, supported by improved gross margins and effective cost management.
  • The cardiovascular segment saw a 70% revenue growth on a local currency basis, driven by strong performance in the US.
  • Pricing strategies and profitability improvement measures have contributed to an improved operating margin by 5 points to 29%.
  • Demand is expanding, especially in the US and China, with company-wide pricing measures having a greater than expected effect.
Negative
  • Free cash flow decreased by 4.2 billion year on year, mainly due to increasing inventories and tariff impacts.
  • TBCT saw a temporary revenue decline due to delayed orders in some regions, although recovery is expected.
  • TMCS medical care solutions experienced a temporary revenue decline due to business divestitures and supply issues.
  • Pharmaceuticals faced lower sales and production delays, negatively impacting profits on a local currency basis.
  • The impact of tariffs is expected to materialize more in the second half of the fiscal year, with challenges in passing the entire amount to prices.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

4543.T - Terumo Corp
Q1 2026 Terumo Corp Earnings Call
Aug 07, 2025 / 08:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Yes, I am. Good day. I'm Haikimoto, CFO.

Thank you for joining our on call today. Let me walk you through today with the Akimoto, me, O Taka, who is responsible for, is, for the IIR will be joining us from April. We have an IR office, an FBI, and also policies are set up by financial team. We actually have this new teams being set up for the business management. Oakasan and I will be responsible for communicating about those financial results.

Thank you in advance for your support. With that, I'd like to make presentations on the financial results for F 52,511. This is the highlight of closure first quarter.

We continue to benefit from favorable business environment, achieving record high quarterly revenue of 260 billion for
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot